ORLANDO -- Challenging medical dogma, the use of intravenous (IV) iron therapy for hospitalized patients with iron deficiency ...

As you're likely aware, last week the CDC's Advisory Committee on Immunization Practices (ACIP) updated its guidance on ...

The battle over enhanced Affordable Care Act subsidies will likely grow more tense this week, with a new plan expected from ...

A conditioning regimen free from total body irradiation (TBI) appeared to be just as effective as standard of care (SoC) in a ...

HHS is tasked with communicating information to protect and improve the health and well-being of every American. It provides ...

Patients with <7/8 transplants had a 1-year survival of 85.6% versus 78.6% for those who received better-matched donor cells.

They don't seek medical care first, but find solace in stories and role models who seem to "get it." But often, the ...

"One of the most serious public health challenges of our time." -- World Health Organization Director-General Tedros Adhanom ...

Early Alzheimer's patients who completed their course of donanemab therapy by 12 months had cognitive and functional benefits lasting for 2 additional years, reported Jennifer Zimmer, MD, of Eli Lilly ...

"Epcoritamab and R 2 is a novel chemotherapy-free fixed-duration therapy that is suitable for outpatient administration and, we believe, sets a new benchmark as a standard of care for second-line [or ...

The aim of the fixed-duration approach is to "produce deep remissions and thereby allow patients to get off therapy while ...